Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective studyIvette F. Emery, Daniel M. Hayes|BMC Cancer|2009Cited by 39
Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.D C Case, Brian M. Dorsk, M C Gerber et al.|PubMed|1990Cited by 33